NEW YORK (GenomeWeb News) – The chairman of the US Senate Judiciary Committee has asked National Institutes of Health Director Francis Collins to invoke a provision in federal law, which has never been used before, to license out Myriad Genetic's BRCA 1 and BRCA 2 gene patents.

Sen. Patrick Leahy (D-Vt.) last week sent a letter to Collins asking him to consider use of the so-called march-in rights under the Bayh-Dole Act "to ensure greater access to genetic testing for breast and ovarian cancer."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.